Industrial Info Resources
New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities with $18.5 Billion in Capital Investment Potential
Industry Segment: Pharmaceutical & Biotech | Word Count: 391 Words
Attachment: Pharma-Biotech New-Build Projects
SUGAR LAND--October 8, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 205 reported new-facility builds in the Pharmaceutical-Biotech Industry, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites represent a potential total capital investment of $18.5 billion, which translates to a per-site average of about $90 million. The "potential" investment for each site includes initial construction, as well as any reported planned future expansions and subsequent phases.
Within this article: Details on key new-build projects in the Pharmaceutical-Biotech Industry, including those from major companies such as Novo Nordisk AS (NYSE:NVO) and Procter & Gamble (NYSE:PG).
Source: http://www.industrialinfo.com/news/abstract.jsp?newsitemID=249650
Market Survey Researcher
The Market Survey Researcher conducts investigative market research via telephone in a HIGH VOLUME OUTBOUND CALLING office environment.
Market Research Analyst
In an office setting, the Market Research Analyst will conduct investigative market research primarily via the telephone in a HIGH VOLUME OUTBOUND CALLING environment.
Energy Research Analyst - Outages
In an office setting, the Market Research Analyst will conduct investigative market research with an emphasis on extracting new power market data and outage events.
Account Receivable/Collections Specialist
The AR Specialist will be responsible for the effective management, analysis and problem resolution of the company’s outstanding accounts and the application of payments.